Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | LCK | P06239 | 1/20 | 0.53 |
| ▸ | FYN | P06241 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | PRKDC | P78527 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | CASP3 | P42574 | 1/20 | 0.52 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31549975 | 1.00 | PKM (0.59) | PKMLMNAPOLBHTTCYP3A4 | |
| Methyl Alcohol SCHEMBL27781670 | 0.98 | PKM (0.58) | PKMLMNAPOLBHTTCYP3A4 | |
| SCHEMBL3698713 | 0.92 | PKM (0.52) | PKMLMNAPOLBHTTCYP3A4 | |
| Methacrylic Acid SCHEMBL28701003 | 0.92 | PKM (0.52) | PKMLMNAPOLBHTTCYP3A4 | |
| SCHEMBL28454415 | 0.91 | PKM (0.58) | PKMLMNAPOLBHTTCYP3A4 | |
| SCHEMBL2903458 | 0.91 | PKM (0.58) | PKMLMNAPOLBHTTCYP3A4 | |
| SCHEMBL23734428 | 0.91 | PKM (0.51) | PKMLMNAPOLBHTTCYP3A4 | |
| SCHEMBL3698716 | 0.91 | PKM (0.51) | PKMLMNAPOLBHTTCYP3A4 | |
| SCHEMBL2610746 | 0.91 | POLB (0.54) | PKMLMNAPOLBHTTCYP3A4 | |
| SCHEMBL20630551 | 0.89 | POLB (0.56) | PKMLMNAPOLBHTTCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 576 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-118420595-A | STING agonist ST-76 and synthetic method and application thereof | 河南牧业经济学院 | 2024-08-02 | — | — | CN | claimed |
| CN-113200861-B | Preparation method and application of 6-nitro veratric acid | 山东科加工业技术研究院有限公司 | 2023-05-09 | — | — | CN | claimed |
| CN-110590683-B | Preparation method of intermediate of targeting drug AZD3759 | 山东四环药业股份有限公司 | 2022-08-19 | — | — | CN | claimed |
| CN-114656435-A | Rockmilan alcohol hydroxyl derivative, preparation method and application thereof | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 2022-06-24 | — | — | CN | claimed |
| CN-114031834-A | High-temperature-resistant, damp-proof, anti-corrosion and anti-aging PE film and preparation method thereof | 江阴市江泰高分子新材料有限公司 | 2022-02-11 | — | — | CN | claimed |
| CN-112171831-B | Wood protective agent and preparation and use methods thereof | 海南博展实业有限公司 | 2021-09-28 | — | — | CN | claimed |
| CN-113200861-A | Novel preparation method and application of 6-nitroveratric acid | 山东科加工业技术研究院有限公司 | 2021-08-03 | — | — | CN | claimed |
| CN-112812016-A | Method for preparing 6-nitro veratric acid from veratric acid by using microchannel reactor | 山东天铭医药科技有限公司 | 2021-05-18 | — | — | CN | claimed |
| US-20050159385-A1 | JAK/STAT inhibitors and MAPK/ERK inhibitors for RSV infection | SOUTH FLORIDA, UNIVERSITY OF | 2005-07-21 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| EP-1310510-A2 | Topologically segregated, encoded solid phase libraries | SELECTIDE CORPORATION (US) | 2003-05-14 | — | — | EP | claimed |
| EP-0705279-B1 | TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES | SELECTIDE CORP (US) | 2003-02-19 | — | — | EP | claimed |
| US-6090912-A | MULTIPLICITY OF SEPARATE SOLID SUPPORTS WITH SURFACE HAVING SUCEPTIBLE LINKER TO SINGLE SPECIES OF TEST COMPOUND AND WITH INTERIOR HAVING ATTACHED NON-CLEAVABLE CODING MOLECULE; FOR SCREENING LIGANDS OR ACCEPTORS | SELECTIDE CORPORATION (US) | 2000-07-18 | — | — | US | claimed |
| EP-0705279-A4 | TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES | SELECTIDE CORP (US) | 1999-03-24 | — | — | EP | claimed |
| US-5840485-A | SYNTHETIC TEST COMPOUNDS ATTACHED TO SEPARATE PHASE SYNTHESIS SUPPORTS THAT ALSO CONTAIN CODING MOLECULES THAT ENCODE THE STRUCTURE OF THE SYNTHETIC TEST COMPOUND | SELECTIDE CORPORATION (US) | 1998-11-24 | — | — | US | claimed |
| US-5547839-A | CONTACTING POLYNUCLEOTIDES WITH SURFACE OF SOLID SUBSTRATE, HYBRIDIZING USING NUCLEIC ACID POLYMERASE AND LABELED NUCLEOTIDE | AFFYMAX TECHNOLOGIES N.V. (AN) | 1996-08-20 | — | — | US | claimed |
| EP-0705279-A1 | TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES | SELECTIDE CORPORATION (US) | 1996-04-10 | — | — | EP | claimed |
| WO-1994028028-A1 | TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES | SELECTIDE CORPORATION (US) | 1994-12-08 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | PKM 3579/4885LMNA 2024/4885POLB 1132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.